Laboratory Of America Holdings Total Assets 2006-2019 | LH

Laboratory Of America Holdings total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Laboratory Of America Holdings total assets for the quarter ending March 31, 2019 were $16.971B, a 0.83% increase year-over-year.
  • Laboratory Of America Holdings total assets for 2018 were $16.185B, a 2.93% decline from 2017.
  • Laboratory Of America Holdings total assets for 2017 were $16.673B, a 17.03% increase from 2016.
  • Laboratory Of America Holdings total assets for 2016 were $14.247B, a 1.01% increase from 2015.
Laboratory Of America Holdings Annual Total Assets
(Millions of US $)
2018 $16,185
2017 $16,673
2016 $14,247
2015 $14,105
2014 $7,302
2013 $6,966
2012 $6,795
2011 $6,112
2010 $6,188
2009 $4,838
2008 $4,670
2007 $4,368
2006 $4,001
2005 $3,876
Laboratory Of America Holdings Quarterly Total Assets
(Millions of US $)
Q1 2019 $16,971
Q4 2018 $16,185
Q3 2018 $16,661
Q2 2018 $16,505
Q1 2018 $16,832
Q4 2017 $16,673
Q3 2017 $16,692
Q2 2017 $14,903
Q1 2017 $14,428
Q4 2016 $14,247
Q3 2016 $14,483
Q2 2016 $14,199
Q1 2016 $14,410
Q4 2015 $14,105
Q3 2015 $14,422
Q2 2015 $14,465
Q1 2015 $14,151
Q4 2014 $7,302
Q3 2014 $7,232
Q2 2014 $7,145
Q1 2014 $6,992
Q4 2013 $6,966
Q3 2013 $6,687
Q2 2013 $6,592
Q1 2013 $6,569
Q4 2012 $6,795
Q3 2012 $6,814
Q2 2012 $6,098
Q1 2012 $6,131
Q4 2011 $6,112
Q3 2011 $6,053
Q2 2011 $6,168
Q1 2011 $6,202
Q4 2010 $6,188
Q3 2010 $5,048
Q2 2010 $4,958
Q1 2010 $4,934
Q4 2009 $4,838
Q3 2009 $4,830
Q2 2009 $4,713
Q1 2009 $4,828
Q4 2008 $4,670
Q3 2008 $4,621
Q2 2008 $4,688
Q1 2008 $4,581
Q4 2007 $4,368
Q3 2007 $4,214
Q2 2007 $4,004
Q1 2007 $3,959
Q4 2006 $4,001
Q3 2006 $4,165
Q2 2006 $4,049
Q1 2006 $3,885
Q4 2005 $3,876
Q3 2005 $3,898
Q2 2005 $3,853
Q1 2005 $3,691
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.194B $11.333B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.596B 20.52
Align Technology (ALGN) United States $25.810B 69.68
McKesson (MCK) United States $23.745B 9.20
AmerisourceBergen (ABC) United States $16.337B 11.60
Cooper (COO) United States $14.453B 25.21
Cardinal Health (CAH) United States $13.422B 8.69
DENTSPLY SIRONA (XRAY) United States $12.735B 26.55
Henry Schein (HSIC) United States $10.125B 17.02
West Pharmaceutical Services (WST) United States $8.554B 39.73
Merit Medical Systems (MMSI) United States $3.019B 31.37
CONMED (CNMD) United States $2.268B 36.18
Patterson (PDCO) United States $2.098B 16.58
Atrion (ATRI) United States $1.638B 46.78
STAAR Surgical (STAA) United States $1.069B 72.85
Antares Pharma (ATRS) United States $0.457B 0.00
Invacare (IVC) United States $0.226B 0.00
Lifevantage (LFVN) United States $0.164B 21.70
Endologix (ELGX) United States $0.117B 0.00
Pro-Dex (PDEX) United States $0.057B 17.64
Biolase (BIOL) United States $0.040B 0.00